id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-E-1102-0005,FDA,FDA-2016-E-1102,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-09-19T04:00:00Z,2017,9,2017-09-19T04:00:00Z,,2017-09-19T13:29:34Z,,0,0,0900006482b4dae8